Figure 11

Immunoscore of F2R expression with anti-pd1 and anti-ctla4 treatment. (A) High and low immune scores in the low and high F2R expression groups while on anti-pd1 therapy. (B) High and low immune scores in the low and high F2R expression groups while on anti-ctla4 therapy.